- Home
- MS vs FDMT Comparison
MS vs FDMT Comparison
Compare MS & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MS
- FDMT
- Stock Information
- Founded
- MS 1924
- FDMT 2013
- Country
- MS United States
- FDMT United States
- Employees
- MS N/A
- FDMT N/A
- Industry
- MS Investment Bankers/Brokers/Service
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- MS Finance
- FDMT Health Care
- Exchange
- MS Nasdaq
- FDMT Nasdaq
- Market Cap
- MS N/A
- FDMT 161.7M
- IPO Year
- MS N/A
- FDMT 2020
- Fundamental
- Price
- MS $128.06
- FDMT $3.62
- Analyst Decision
- MS Buy
- FDMT Buy
- Analyst Count
- MS 15
- FDMT 10
- Target Price
- MS $132.46
- FDMT $32.33
- AVG Volume (30 Days)
- MS 5.9M
- FDMT 461.1K
- Earning Date
- MS 07-16-2025
- FDMT 05-08-2025
- Dividend Yield
- MS 2.89%
- FDMT N/A
- EPS Growth
- MS 55.47
- FDMT N/A
- EPS
- MS 8.53
- FDMT N/A
- Revenue
- MS $63,959,000,000.00
- FDMT $23,000.00
- Revenue This Year
- MS $10.01
- FDMT $13,097.30
- Revenue Next Year
- MS $4.03
- FDMT N/A
- P/E Ratio
- MS $15.01
- FDMT N/A
- Revenue Growth
- MS 17.42
- FDMT N/A
- 52 Week Low
- MS $90.94
- FDMT $2.24
- 52 Week High
- MS $142.03
- FDMT $28.93
- Technical
- Relative Strength Index (RSI)
- MS 55.56
- FDMT 54.49
- Support Level
- MS $123.88
- FDMT $3.37
- Resistance Level
- MS $129.53
- FDMT $3.81
- Average True Range (ATR)
- MS 2.40
- FDMT 0.27
- MACD
- MS -0.43
- FDMT 0.02
- Stochastic Oscillator
- MS 30.55
- FDMT 67.42
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.